Down-regulation of vesicular glutamate transporters precedes cell loss and pathology in Alzheimer's disease

Journal of Neurochemistry

Volumn 98, Issue 3, 2006, Pages 939-950

  Kirvell, Sara L ^a   Esiri, Margaret ^b   Francis, Paul T ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Alzheimer's disease; Dementia; Glutamate; Synapse; Vesicular transporter

Indexed keywords

BRAIN PROTEIN; PROTEIN ANTIBODY; SYNAPTOPHYSIN; VESICULAR GLUTAMATE TRANSPORTER;

AGED; ALZHEIMER DISEASE; ANTIBODY LABELING; ARTICLE; BEHAVIOR; BRAIN LEVEL; BRAIN REGION; CELL LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE MARKER; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MENTAL TEST; NERVE CELL; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; OCCIPITAL CORTEX; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; SCORING SYSTEM; SYNAPSE VESICLE; TEMPORAL CORTEX; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANIMALS; BRAIN; CELL COUNT; CELL DEATH; DOWN-REGULATION; FEMALE; HUMANS; MALE; RATS; TIME FACTORS; VESICULAR GLUTAMATE TRANSPORT PROTEINS;

EID: 33745920510     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03935.x     Document Type: Article

References (72)

1. +-dependent inorganic phosphate cotransporter. J. Neurochem. 74, 2622-2625.
2. Baudry M. and Lynch G. (2001) Remembrance of arguments past: how well is the glutamate receptor hypothesis of LTP holding up after 20 years? Neurobiol. Learn. Mem. 76, 284-297.
3. Bellocchio E. E., Hu H., Pohorille A., Chan J., Pickel V. M. and Edwards R. H. (1998) The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J. Neurosci. 18, 8648-8659.
4. Bellocchio E. E., Reimer R. J., Fremeau R. T. Jr and Edwards R. H. (2000) Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289, 957-960.
5. Bowen D. M., Smith C. B., White P. and Davison A. N. (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99, 459-496.
6. Bowen D. M., Najlerahim A., Procter A. W., Francis P. T. and Murphy E. (1989) Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life. Proc. Natl Acad. Sci. USA 86, 9504-9508.
7. Braak H. and Braak E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82, 239-259.
8. Braak H. and Braak E. (1998) Evolution of neuronal changes in the course of Alzheimer's disease. J. Neural Transm. Suppl. 53, 127-140.
9. Brun (1983) An overview of light and electron microscopic changes, in Alzheimer's Disease the Standard Reference (Reisberg B., ed.), pp. 37-47. The Free Press, New York.
10. Carlini W. and Ransom B. (1990) Fabrication and implementation of ion-sensitive microelectrodes, in Neurophysiological Techniques, Basic Methods and Concepts (Boulton A. A., Barker G. B. and Vanderwolf C. H., eds), pp. 227-319. Humana Press, New Jersey.
11. Coleman P. D. and Yao P. J. (2003) Synaptic slaughter in Alzheimer's disease. Neurobiol. Aging 24, 1023-1027.
12. Cousin M. A. and Robinson P. J. (1999) Mechanisms of synaptic vesicle recycling illuminated by fluorescent dyes. J. Neurochem. 73, 2227-2239.
13. Cowburn R., Hardy J., Roberts P. and Briggs R. (1988) Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease. Neurosci. Lett. 86, 109-113.
14. 3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases. Neurosci. Lett. 79, 213-217.
15. Danbolt N. C. (2001) Glutamate uptake. Prog. Neurobiol. 65, 1-105.
16. Danik M., Cassoly E., Manseau F., Sotty F., Mouginot D. and Williams S. (2005) Frequent coexpression of the vesicular glutamate transporter 1 and 2 genes, as well as coexpression with genes for choline acetyltransferase or glutamic acid decarboxylase in neurons of rat brain. J. Neurosci. Res. 81, 506-521.
17. Folstein M. F., Folstein S. E. and McHugh P. R. (1975) 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189-198.
18. Fonnum F. (1984) Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42, 1-11.
19. Francis P. T. (2003) Glutamatergic systems in Alzheimer's disease. Int. J. Geriatr. Psychiatry 18, S15-S21.
20. Francis P. T., Sims N. R., Procter A. W. and Bowen D. M. (1993) Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives. J. Neurochem. 60, 1589-1604.
21. Francis P. T., Palmer A. M., Snape M. and Wilcock G. K. (1999) The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 66, 137-147.
22. Fremeau R. T. Jr, Troyer M. D., Pahner I., Nygaard G. O., Tran C. H., Reimer R. J., Bellocchio E. E., Fortin D., Storm-Mathisen J. and Edwards R. H. (2001) The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31, 247-260.
23. Fremeau R. T. Jr, Burman J., Qureshi T. et al. (2002) The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc. Natl Acad. Sci. USA 99, 14 488-14 493.
24. Fremeau R. T. Jr, Voglmaier S., Seal R. P. and Edwards R. H. (2004) VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci. 27, 98-103.
25. Fujiyama F., Furuta T. and Kaneko T. (2001) Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex. J. Comp. Neurol. 435, 379-387.
26. Gras C., Herzog E., Bellenchi G. C., Bernard V., Ravassard P., Pohl M., Gasnier B., Giros B. and El Mestikawy S. (2002) A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J. Neurosci. 22, 5442-5451.
27. Greenamyre J. T., Maragos W. F., Albin R. L., Penney J. B. and Young A. B. (1988) Glutamate transmission and toxicity in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 12, 421-430.
28. Hardy J., Cowburn R., Barton A., Reynolds G., Lofdahl E., O'Carroll A. M., Wester P. and Winblad B. (1987) Region-specific loss of glutamate innervation in Alzheimer's disease. Neurosci. Lett. 73, 77-80.
29. Haug L. S., Ostvold A. C., Cowburn R. F., Garlind A., Winblad B., Bogdanovich N. and Walaas S. I. (1996) Decreased inositol (1,4,5)-trisphosphate receptor levels in Alzheimer's disease cerebral cortex: selectivity of changes and possible correlation to pathological severity. Neurodegeneration. 5, 169-176.
30. Herzog E., Bellenchi G. C., Gras C., Bernard V., Ravassard P., Bedet C., Gasnier B., Giros B. and El Mestikawy S. (2001) The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J. Neurosci. 21, RC181.
31. Herzog E., Gilchrist J., Gras C., Muzerelle A., Ravassard P., Giros B., Gaspar P. and El M. S. (2004) Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain. Neuroscience 123, 983-1002.
32. Honer W. G., Dickson D. W., Gleeson J. and Davies P. (1992) Regional synaptic pathology in Alzheimer's disease. Neurobiol. Aging 13, 375-382.
33. Hope T. and Fairburn C. G. (1992) The Present Behavioural Examination (PBE): the development of an interview to measure current behavioural abnormalities. Psychol. Med. 22, 223-230.
34. Hope T., Keene J., Fairburn C., McShane R. and Jacoby R. (1997a) Behaviour changes in dementia. 2: Are there behavioural syndromes? Int. J. Geriatr. Psychiatry 12, 1074-1078.
35. Hope T., Keene J., Gedling K., Cooper S., Fairburn C. and Jacoby R. (1997b) Behaviour changes in dementia. 1: Point of entry data of a prospective study. Int. J. Geriatr. Psychiatry 12, 1062-1073.
36. Hyman B. T., Van Hoesen G. W. and Damasio A. R. (1987) Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann. Neurol. 22, 37-40.
37. Hyvarinen J. (1982) Posterior parietal lobe of the primate brain. Physiol. Rev. 62, 1060-1129.
38. Kaneko T. and Fujiyama F. (2002) Complementary distribution of vesicular glutamate transporters in the central nervous system. Neurosci. Res. 42, 243-250.
39. Kaneko T., Fujiyama F. and Hioki H. (2002) Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain. J. Comp. Neurol. 444, 39-62.
40. Kim S. H., Kook M. C., Shin Y. K., Park S. H. and Song H. G. (2004) Evaluation of antigen retrieval buffer systems. J. Mol. Histol. 35, 409-416.
41. Lee H. G., Zhu X., Ghanbari H. A., Ogawa O., Raina A. K., O'Neill M. J., Perry G. and Smith M. A. (2002) Differential regulation of glutamate receptors in Alzheimer's disease. Neurosignals 11, 282-292.
42. Masliah E., Terry R. D., DeTeresa R. M. and Hansen L. A. (1989) Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease. Neurosci. Lett. 103, 234-239.
43. Masliah E., Mallory M., Hansen L., DeTeresa R., Alford M. and Terry R. (1994) Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci. Lett. 174, 67-72.
44. Masliah E., Mallory M., Alford M., DeTeresa R., Hansen L. A., McKeel D. W. Jr and Morris J. C. (2001) Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56, 127-129.
45. Matthews K. L., Chen C. P., Esiri M. M., Keene J., Minger S. L. and Francis P. T. (2002) Noradrenergic changes, aggressive behavior, and cognition in patients with dementia. Biol. Psychiatry 51, 407-416.
46. Minger S. L., Esiri M. M., McDonald B., Keene J., Carter J., Hope T. and Francis P. T. (2000) Cholinergic deficits contribute to behavioral disturbance in patients with dementia. Neurology 55, 1460-1467.
47. Morrison J. H. and Hof P. R. (1997) Life and death of neurons in the aging brain. Science 278, 412-419.
48. Najlerahim A. and Bowen D. M. (1988) Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type. Acta Neuropathol. (Berl.) 75, 509-512.
49. Neary D., Snowden J. S., Mann D. M., Bowen D. M., Sims N. R., Northen B., Yates P. O. and Davison A. N. (1986) Alzheimer's disease: a correlative study. J. Neurol. Neurosurg. Psychiatry 49, 229-237.
50. +- dependent inorganic phosphate cotransporter. Proc. Natl Acad. Sci. USA 91, 5607-5611.
51. Nieto A., Montejo de G. E. and Avila J. (1989) Altered levels of microtubule proteins in brains of Alzheimer's disease patients. Acta Neuropathol. (Berl.) 78, 47-51.
52. Obrenovitch T. P. and Urenjak J. (1997) Altered glutamatergic transmission in neurological disorders: from high extracellular glutamate to excessive synaptic efficacy. Prog. Neurobiol. 51, 39-87.
53. Padovan C. M. and Guimaraes F. S. (2004) Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats. Pharmacol. Biochem. Behav. 77, 15-19.
54. Palmer A. M., Procter A. W., Stratmann G. C. and Bowen D. M. (1986) Excitatory amino acid-releasing and cholinergic neurones in Alzheimer's disease. Neurosci. Lett. 66, 199-204.
55. Perry E. K., Gibson P. H., Blessed G., Perry R. H. and Tomlinson B. E. (1977) Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J. Neurol. Sci. 34, 247-265.
56. Procter A. W., Palmer A. M., Francis P. T., Lowe S. L., Neary D., Murphy E., Doshi R. and Bowen D. M. (1988) Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J. Neurochem. 50, 790-802.
57. Purves R. D. (1981) Biological Techniques Series, volume 6: Microelectrode Methods for Intracellular Recording and Ionophoresis. Academic, New York.
58. Rylett R. J., Ball M. J. and Colhoun E. H. (1983) Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res. 289, 169-175.
59. Schafer M. K., Varoqui H., Defamie N., Weihe E. and Erickson J. D. (2002) Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J. Biol. Chem. 277, 50 734-50 748.
60. Sims N. R., Bowen D. M., Allen S. J., Smith C. C., Neary D., Thomas D. J. and Davison A. N. (1983) Presynaptic cholinergic dysfunction in patients with dementia. J. Neurochem. 40, 503-509.
61. Sze C. I., Troncoso J. C., Kawas C., Mouton P., Price D. L. and Martin L. J. (1997) Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56, 933-944.
62. Sze C. I., Bi H., Kleinschmidt-DeMasters B. K., Filley C. M. and Martin L. J. (2000) Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. J. Neurol. Sci. 175, 81-90.
63. Takamori S., Rhee J. S., Rosenmund C. and Jahn R. (2000) Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407, 189-194.
64. Takamori S., Rhee J. S., Rosenmund C. and Jahn R. (2001) Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J. Neurosci. 21, RC182.
65. Takamori S., Malherbe P., Broger C. and Jahn R. (2002) Molecular cloning and functional characterization of human vesicular glutamate transporter 3. EMBO Report 3, 798-803.
66. Terry R. D., Masliah E., Salmon D. P., Butters N., DeTeresa R., Hill R., Hansen L. A. and Katzman R. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580.
67. +/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. J. Neurosci. 22, 142-155.
68. Westphalen R. I., Scott H. L. and Dodd P. R. (2003) Synaptic vesicle transport and synaptic membrane transporter sites in excitatory amino acid nerve terminals in Alzheimer disease. J. Neural Transm. 110, 1013-1027.
69. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T. and Delon M. R. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215, 1237-1239.
70. Wiedenmann B. and Franke W. W. (1985) Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41, 1017-1028.
71. Zilles K. (1990) Cortex, in The Human Nervous System (Paxinos G., ed.), pp. 757-802. Academic Press: San Diego, USA.
72. Zorumski C. F. and Olney J. W. (1993) Excitotoxic neuronal damage and neuropsychiatric disorders. Pharmacol. Ther. 59, 145-162.